Utilisation of exome sequencing for muscular disorders in Thai paediatric patients: diagnostic yield and mutational spectrum.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
25 01 2023
25 01 2023
Historique:
received:
02
09
2022
accepted:
18
01
2023
entrez:
25
1
2023
pubmed:
26
1
2023
medline:
28
1
2023
Statut:
epublish
Résumé
Muscular dystrophies and congenital myopathies are heterogeneous groups of inherited muscular disorders. An accurate diagnosis is challenging due to their complex clinical presentations and genetic heterogeneity. This study aimed to determine the utilisation of exome sequencing (ES) for Thai paediatric patients with muscular disorders. Of 176 paediatric patients suspected of genetic/inherited myopathies, 133 patients received a molecular diagnosis after performing conventional investigations, single gene testing, and gene panels. The remaining 43 patients from 42 families could be classified into three groups: Group 1, MLPA-negative Duchenne muscular dystrophy (DMD) with 9 patients (9/43; 21%), Group 2, other muscular dystrophies (MD) with 18 patients (18/43; 42%) and Group 3, congenital myopathies (CM) with 16 patients (16/43; 37%). All underwent exome sequencing which could identify pathogenic variants in 8/9 (89%), 14/18 (78%), and 8/16 (50%), for each Group, respectively. Overall, the diagnostic yield of ES was 70% (30/43) and 36 pathogenic/likely pathogenic variants in 14 genes were identified. 18 variants have never been previously reported. Molecular diagnoses provided by ES changed management in 22/30 (73%) of the patients. Our study demonstrates the clinical utility and implications of ES in inherited myopathies.
Identifiants
pubmed: 36697461
doi: 10.1038/s41598-023-28405-6
pii: 10.1038/s41598-023-28405-6
pmc: PMC9876991
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1376Informations de copyright
© 2023. The Author(s).
Références
PLoS One. 2013;8(1):e53083
pubmed: 23326386
Neuromuscul Disord. 2014 Feb;24(2):97-116
pubmed: 24456932
Science. 2009 Feb 27;323(5918):1205-8
pubmed: 19251627
Orphanet J Rare Dis. 2015 Nov 17;10:148
pubmed: 26578207
Lancet. 2013 Mar 9;381(9869):845-60
pubmed: 23465426
Orphanet J Rare Dis. 2019 Dec 2;14(1):276
pubmed: 31791368
Clin Genet. 2021 Dec;100(6):703-712
pubmed: 34496037
Neurology. 2010 Aug 31;75(9):807-14
pubmed: 20668259
Orphanet J Rare Dis. 2017 Sep 6;12(1):151
pubmed: 28877744
Arq Neuropsiquiatr. 2017 Nov;75(11):789-795
pubmed: 29236822
Neuromuscul Disord. 2018 Dec;28(12):986-995
pubmed: 30342905
Orphanet J Rare Dis. 2019 Feb 26;14(1):57
pubmed: 30808424
Lancet. 2017 Sep 23;390(10101):1489-1498
pubmed: 28728956
PLoS One. 2013 Jun 24;8(6):e67527
pubmed: 23826317
Neuromuscul Disord. 2020 Dec;30(12):1008-1048
pubmed: 33257164
J Med Genet. 2015 Mar;52(3):208-16
pubmed: 25635128
Acta Neuropathol. 2021 Mar;141(3):431-453
pubmed: 33449170
PLoS One. 2021 Jun 9;16(6):e0252953
pubmed: 34106991
Neuropediatrics. 2019 Apr;50(2):96-102
pubmed: 30665247
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868